http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2344730-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a5824b72a18cc4c56d5aa538f308e90 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
| filingDate | 2001-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37c23b7a4aaa2eb68b89bb751f99972b |
| publicationDate | 2010-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2344730-T3 |
| titleOfInvention | PHARMACOLOGICAL COMPOSITION FOR NASAL ADMINISTRATION OF FENTANIL. |
| abstract | Pharmacological composition for nasal administration, containing fentanyl as active ingredient with an active substance content of 0.001 to 20.0% by weight, in each case with respect to the total weight of the pharmacological composition, hyaluronic acid and / or its salts with a weight molecular between 2 million and 3 million dalton and with a hyaluronic acid content and / or its salts of 0.01 to 0.2% by weight, with respect to the total amount of the pharmacological composition, and possibly at least one solubilizing agent and / or an adjuvant. |
| priorityDate | 2000-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.